SCHEMBL6092832

SCHEMBL6092832

O=C(O)c1ccc2c(c1)CCCN2C(=O)OCC1c2ccccc2-c2ccccc21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK1 Q15118 3/20 0.46
PDK2 Q15119 3/20 0.46
PDK3 Q15120 3/20 0.46
PDK4 Q16654 3/20 0.46
KDM4E B2RXH2 1/20 0.46
MCL1 Q07820 2/20 0.43
ALDH1A1 P00352 2/20 0.42
TSHR P16473 2/20 0.42
GAA P10253 1/20 0.42
MAPT P10636 1/20 0.42
ALOX15 P16050 1/20 0.42
CASP1 P29466 1/20 0.42
HTT P42858 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
RAB9A P51151 2/20 0.41
SRD5A1 P18405 1/20 0.40
SRD5A2 P31213 1/20 0.40
NPC1 O15118 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
CREBBP Q92793 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29581976 0.86 KDM4E (0.44) PDK1PDK2PDK3PDK4KDM4E
SCHEMBL29581337 0.85 KDM4E (0.42) PDK1PDK2PDK3PDK4KDM4E
SCHEMBL5781672 0.82 KDM4E (0.42) PDK1PDK2PDK3PDK4KDM4E
SCHEMBL5781674 0.82 KDM4E (0.42) PDK1PDK2PDK3PDK4KDM4E
SCHEMBL18392314 0.81 RAB9A (0.63) PDK1PDK2PDK3PDK4KDM4E
SCHEMBL18109833 0.80 PDK1 (0.50) PDK1PDK2PDK3PDK4KDM4E
SCHEMBL31532294 0.78 TMEM97 (0.46) SRD5A1SRD5A2PRMT5WDR77FABP7
SCHEMBL29341760 0.78 TMEM97 (0.46) SRD5A1SRD5A2PRMT5WDR77FABP7
SCHEMBL31532280 0.78 TMEM97 (0.46) SRD5A1SRD5A2PRMT5WDR77FABP7
SCHEMBL16424441 0.78 KMT2A (0.44) KDM4ETSHRMAPTRAB9AFABP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4400505-A1 PEPTIDE-UREA DERIVATIVE, PHARMACEUTICAL COMPOSITION CONTAINING SAME AND APPLICATION THEREOF Bivision Pharmaceuticals, Inc (CN) 2024-07-17 EP disclosed
WO-2007144379-A1 BICYCLIC COMPOUNDS USEFUL AS CATHEPSIN S INBHIBITORS MEDIVIR AB (SE) 2007-12-21 WO disclosed
WO-2006064286-A1 CATHEPSIN S INHIBITORS MEDIVIR UK LTD (GB) 2006-06-22 WO disclosed
WO-2006064286-A1 CATHEPSIN S INHIBITORS MEDIVIR UK LTD (GB) 2006-06-22 WO disclosed